ARCB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ArcBest Corp (ARCB) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive indicators such as insider buying and bullish technical trends, the company's recent financial performance shows significant declines in revenue, net income, and EPS, which raises concerns about its long-term growth potential. Additionally, the lack of recent news or significant catalysts, coupled with mixed analyst ratings and price target adjustments, suggests that waiting for clearer signs of improvement may be prudent.
The technical indicators for ARCB are moderately bullish. The MACD is positively expanding above 0, and the moving averages are in a bullish alignment (SMA_5 > SMA_20 > SMA_200). However, the RSI is at 75.056, which is in the neutral zone and does not provide a strong buy signal. The stock is trading near its resistance level (R1: 100.46), which could act as a barrier to further upward movement.
Insider buying has increased significantly by 284.68% over the last month, indicating confidence from company insiders.
Bullish technical indicators such as MACD and moving averages suggest short-term upward momentum.
The company's financial performance in Q4 2025 shows significant declines in revenue (-2.89% YoY), net income (-127.95% YoY), and EPS (-129.27% YoY).
Mixed analyst ratings and price target adjustments, with some analysts lowering targets due to weaker-than-expected performance.
No recent news or significant event-driven catalysts to drive investor sentiment.
In Q4 2025, ArcBest reported a revenue decline of -2.89% YoY to $972.7M, net income dropped to -$8.12M (-127.95% YoY), and EPS fell to -$0.36 (-129.27% YoY). Gross margin also declined by -2.30% YoY to 80.83. These figures indicate a challenging financial quarter with declining profitability.
Analyst ratings are mixed. Citi and Jefferies maintain Buy ratings with price targets of $107 and $125, respectively, citing improving trends and the company's strong physical asset base. However, JPMorgan, BofA, and others maintain Neutral ratings, with some lowering price targets due to weaker-than-expected performance in February and Q4 results.
